These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36762699)

  • 1. Discovery of AcrAB-TolC pump inhibitors: Virtual screening and molecular dynamics simulation approach.
    Phan TV; Nguyen VT; Nguyen CH; Vu TT; Tran TD; Le MT; Trinh DT; Tran VH; Thai KM
    J Biomol Struct Dyn; 2023; 41(22):12503-12520. PubMed ID: 36762699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escherichia coli resistance mechanism AcrAB-TolC efflux pump interactions with commonly used antibiotics: a molecular dynamics study.
    Smith BL; Fernando S; King MD
    Sci Rep; 2024 Feb; 14(1):2742. PubMed ID: 38302495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
    Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
    mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
    Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation.
    Aparna V; Dineshkumar K; Mohanalakshmi N; Velmurugan D; Hopper W
    PLoS One; 2014; 9(7):e101840. PubMed ID: 25025665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational assessment and
    Phan TV; Tuong LT; Nguyen VT; Vo CT; Tran TD; Le MT; Nguyen BGD; Tran VT; Vu TT; Thai KM
    J Biomol Struct Dyn; 2023 Dec; ():1-13. PubMed ID: 38088368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The search of potential inhibitors of the AcrAB-TolC system of multidrug-resistant Escherichia coli: an in silico approach.
    Abdel-Halim H; Al Dajani A; Abdelhalim A; Abdelmalek S
    Appl Microbiol Biotechnol; 2019 Aug; 103(15):6309-6318. PubMed ID: 31209525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Interactions of Carbapenem Antibiotics with the Multidrug Efflux Transporter AcrB of
    Atzori A; Malloci G; Cardamone F; Bosin A; Vargiu AV; Ruggerone P
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump.
    Compagne N; Jiménez-Castellanos JC; Meurillon V; Pradel E; Vieira Da Cruz A; Piveteau C; Biela A; Eveque M; Leroux F; Deprez B; Willand N; Hartkoorn RC; Flipo M
    Eur J Med Chem; 2023 Nov; 259():115630. PubMed ID: 37459793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering a CRISPR interference system targeting AcrAB-TolC efflux pump to prevent multidrug resistance development in Escherichia coli.
    Wan X; Li Q; Olsen RH; Meng H; Zhang Z; Wang J; Zheng H; Li L; Shi L
    J Antimicrob Chemother; 2022 Jul; 77(8):2158-2166. PubMed ID: 35642356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from
    Alenazy R
    Biology (Basel); 2022 Sep; 11(9):. PubMed ID: 36138807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of carbapenem binding sites within the RND-transporter AcrB.
    Atzori A; Malviya VN; Malloci G; Dreier J; Pos KM; Vargiu AV; Ruggerone P
    Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):62-74. PubMed ID: 30416087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the organic solvent tolerance of Escherichia coli with vanillin, and the involvement of an AcrAB-TolC efflux pump in vanillin tolerance.
    Ikehata Y; Doukyu N
    J Biosci Bioeng; 2022 Apr; 133(4):347-352. PubMed ID: 35063375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-silico interaction studies suggest RND efflux pump mediates polymyxin resistance in Acinetobacter baumannii.
    Verma P; Maurya P; Tiwari M; Tiwari V
    J Biomol Struct Dyn; 2019 Jan; 37(1):95-103. PubMed ID: 29246087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters.
    Hayashi K; Nakashima R; Sakurai K; Kitagawa K; Yamasaki S; Nishino K; Yamaguchi A
    J Bacteriol; 2016 Jan; 198(2):332-42. PubMed ID: 26527645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2019 Garrod Lecture: MDR efflux in Gram-negative bacteria-how understanding resistance led to a new tool for drug discovery.
    Piddock LJV
    J Antimicrob Chemother; 2019 Nov; 74(11):3128-3134. PubMed ID: 31626705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer simulations suggest direct and stable tip to tip interaction between the outer membrane channel TolC and the isolated docking domain of the multidrug RND efflux transporter AcrB.
    Schmidt TH; Raunest M; Fischer N; Reith D; Kandt C
    Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1419-26. PubMed ID: 27045078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational assessment of phytochemicals of medicinal plants from Mexico as potential inhibitors of
    Oyedara OO; Fadare OA; Franco-Frías E; Heredia N; García S
    J Biomol Struct Dyn; 2023 Mar; 41(5):1776-1789. PubMed ID: 34996337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding site feature description of 2-substituted benzothiazoles as potential AcrAB-TolC efflux pump inhibitors in E. coli.
    Yilmaz S; Altinkanat-Gelmez G; Bolelli K; Guneser-Merdan D; Ufuk Over-Hasdemir M; Aki-Yalcin E; Yalcin I
    SAR QSAR Environ Res; 2015; 26(10):853-71. PubMed ID: 26559566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
    Wang-Kan X; Rodríguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.